NEKTAR THERAPEUTICS Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Nektar Therapeutics quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Nektar Therapeutics Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 184M shares, a 3.31% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 184M -6.31M -3.31% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 184M -6.06M -3.19% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 184M -5.61M -2.97% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 191M +2.82M +1.5% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 191M +2.82M +1.5% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 190M +2.71M +1.45% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 189M +2.96M +1.59% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 189M +3.09M +1.67% Dec 31, 2022 10-K 2024-03-05
Q3 2022 188M +3.4M +1.84% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 187M +3.63M +1.98% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 186M +3.98M +2.19% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 185M +5.38M +2.99% Dec 31, 2021 10-K 2023-02-28
Q3 2021 185M +5.16M +2.88% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 184M +4.96M +2.78% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 182M +4.43M +2.49% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 180M +3.59M +2.03% Dec 31, 2020 10-K 2022-03-01
Q3 2020 179M +3.61M +2.05% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 179M +3.84M +2.2% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 178M +3.64M +2.09% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 177M +2.98M +1.71% Dec 31, 2019 10-K 2021-02-26
Q3 2019 176M +2.73M +1.58% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 175M +2.55M +1.48% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 174M +11.8M +7.3% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 174M +14M +8.78% Dec 31, 2018 10-K 2020-02-28
Q3 2018 173M +16.1M +10.3% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 172M +16.6M +10.6% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 162M +7.65M +4.94% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 160M +6.31M +4.12% Dec 31, 2017 10-K 2019-03-01
Q3 2017 157M +19.2M +13.9% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 156M +19.3M +14.1% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 155M +18.6M +13.6% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 153M +17.9M +13.2% Dec 31, 2016 10-K 2018-03-01
Q3 2016 138M +4.58M +3.44% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 137M +4.42M +3.34% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 136M +4.7M +3.58% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 135M +4.07M +3.1% Dec 31, 2015 10-K 2017-03-01
Q3 2015 133M +4.97M +3.88% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 132M +4.9M +3.85% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 131M +4.52M +3.56% Mar 31, 2015 10-Q 2015-05-01
Q4 2014 131M +14.7M +12.6% Dec 31, 2014 10-K 2016-03-01
Q3 2014 128M +12.3M +10.6% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 127M +11.6M +10% Jun 30, 2014 10-Q 2014-08-01
Q1 2014 127M +11.5M +9.94% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 116M +1.24M +1.07% Dec 31, 2013 10-K 2015-02-26
Q3 2013 116M +917K +0.8% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 116M +903K +0.79% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 115M +870K +0.76% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 115M +774K +0.68% Dec 31, 2012 10-K 2014-02-27
Q3 2012 115M +647K +0.57% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 115M +475K +0.42% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 115M +568K +0.5% Mar 31, 2012 10-Q 2012-05-04
Q4 2011 114M +20M +21.1% Dec 31, 2011 10-K 2013-03-01
Q3 2011 114M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 114M Jun 30, 2011 10-Q 2011-08-05
Q1 2011 114M Mar 31, 2011 10-Q 2011-04-29
Q4 2010 94.5M Dec 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.